LANCL1
Basic information
Region (hg38): 2:210427131-210477652
Previous symbols: [ "GPR69A" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LANCL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 32 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 0 | 2 |
Variants in LANCL1
This is a list of pathogenic ClinVar variants found in the LANCL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-210435393-A-G | not specified | Uncertain significance (Jul 15, 2021) | ||
2-210436259-T-C | not specified | Uncertain significance (May 20, 2024) | ||
2-210436274-G-C | not specified | Uncertain significance (Aug 10, 2023) | ||
2-210436296-C-T | not specified | Uncertain significance (May 20, 2024) | ||
2-210436298-T-G | not specified | Uncertain significance (Nov 29, 2021) | ||
2-210436331-T-C | not specified | Uncertain significance (Feb 16, 2023) | ||
2-210436335-G-T | not specified | Uncertain significance (Mar 24, 2023) | ||
2-210436358-T-C | not specified | Uncertain significance (Oct 03, 2022) | ||
2-210437692-T-C | not specified | Uncertain significance (Jun 29, 2023) | ||
2-210437710-T-C | not specified | Uncertain significance (May 23, 2023) | ||
2-210437728-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
2-210440624-C-T | not specified | Uncertain significance (Apr 01, 2024) | ||
2-210440633-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
2-210441354-T-C | not specified | Uncertain significance (May 24, 2023) | ||
2-210441359-A-C | not specified | Uncertain significance (Mar 07, 2024) | ||
2-210441387-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
2-210441399-A-G | not specified | Uncertain significance (Jun 16, 2023) | ||
2-210441411-G-T | not specified | Uncertain significance (Mar 02, 2023) | ||
2-210441437-A-C | Benign (Oct 24, 2018) | |||
2-210455117-A-G | not specified | Uncertain significance (Oct 12, 2021) | ||
2-210455162-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
2-210455228-G-C | not specified | Uncertain significance (Jun 05, 2024) | ||
2-210455233-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
2-210455249-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
2-210455267-C-T | not specified | Uncertain significance (Jul 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LANCL1 | protein_coding | protein_coding | ENST00000443314 | 9 | 46404 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.08e-11 | 0.163 | 125668 | 0 | 80 | 125748 | 0.000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.743 | 248 | 217 | 1.14 | 0.0000108 | 2595 |
Missense in Polyphen | 94 | 89.605 | 1.0491 | 1131 | ||
Synonymous | -0.278 | 85 | 81.8 | 1.04 | 0.00000400 | 755 |
Loss of Function | 0.714 | 19 | 22.7 | 0.838 | 0.00000111 | 272 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000740 | 0.000726 |
Ashkenazi Jewish | 0.000398 | 0.000397 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000323 | 0.000323 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.00150 | 0.00134 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in EPS8 signaling. Binds glutathione. {ECO:0000269|PubMed:19528316}.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.846
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 69.46
Haploinsufficiency Scores
- pHI
- 0.238
- hipred
- N
- hipred_score
- 0.350
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.793
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lancl1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway
- Cellular component
- cytoplasm;plasma membrane;integral component of plasma membrane
- Molecular function
- catalytic activity;G protein-coupled receptor activity;protein binding;zinc ion binding;SH3 domain binding;glutathione binding;low-density lipoprotein particle receptor binding